Literature DB >> 3617430

Inhibition of malate dehydrogenase enzymes by benzimidazole anthelmintics.

P Tejada, M Sanchez-Moreno, M Monteoliva, H Gomez-Banqueri.   

Abstract

Determinations were made of the inhibitory activities of four benzimidazole anthelmintics (Albendazole, Parbendazole, Mebendazole and Thiabendazole) on purified extracts of cytoplasmic and mitochondrial malate dehydrogenase obtained from Ascaris suum, Fasciola hepatica and Moniezia expansa. The highest percentage inhibitions were exhibited by Mebendazole. The results confirm that cytoplasmic MDH and mitochondrial MDH regulator enzymes of glycogen synthesis are the sites of mebendazole inhibitory activity, but the activity sites of the other anthelmintics in the study remain unclear.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3617430     DOI: 10.1016/0304-4017(87)90048-3

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  5 in total

1.  Visnagin protects against doxorubicin-induced cardiomyopathy through modulation of mitochondrial malate dehydrogenase.

Authors:  Yan Liu; Aarti Asnani; Lin Zou; Victoria L Bentley; Min Yu; You Wang; Graham Dellaire; Kumar S Sarkar; Matthew Dai; Howard H Chen; David E Sosnovik; Jordan T Shin; Daniel A Haber; Jason N Berman; Wei Chao; Randall T Peterson
Journal:  Sci Transl Med       Date:  2014-12-10       Impact factor: 17.956

2.  A BRIEF REVIEW ON THE MODE OF ACTION OF ANTINEMATODAL DRUGS.

Authors:  Melanie Abongwa; Richard J Martin; Alan P Robertson
Journal:  Acta Vet (Beogr)       Date:  2017-06-26       Impact factor: 0.800

3.  Identification of small molecule enzyme inhibitors as broad-spectrum anthelmintics.

Authors:  Rahul Tyagi; Mostafa A Elfawal; Scott A Wildman; Jon Helander; Christina A Bulman; Judy Sakanari; Bruce A Rosa; Paul J Brindley; James W Janetka; Raffi V Aroian; Makedonka Mitreva
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

4.  EgGLUT1 Is Crucial for the Viability of Echinococcus granulosus sensu stricto Metacestode: A New Therapeutic Target?

Authors:  Kuerbannisha Amahong; Mingzhi Yan; Jintian Li; Ning Yang; Hui Liu; Xiaojuan Bi; Dominique A Vuitton; Renyong Lin; Guodong Lü
Journal:  Front Cell Infect Microbiol       Date:  2021-11-11       Impact factor: 5.293

5.  Molecular docking and dynamic simulations of benzimidazoles with beta-tubulins.

Authors:  Chennu Maruthi Malya Prasada Rao; Narapusetty Naidu; Jhansi Priya; K Poorna Chandra Rao; Kapu Ranjith; Singarapalle Shobha; Bodepudi Sudheer Chowdary; Sridhar Siddiraju; Sabitha Yadam
Journal:  Bioinformation       Date:  2021-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.